Cingulate Inc. (CINGW)Kansas City, United States | NasdaqCM
0.01 USD
+0.01
(171.875%)
⇧
(Oct. 14, 2026, 1:53 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:41 a.m. EDT
The immediate outlook is bearish as the stock tests its 52-week low of $0.0035, signaling severe selling pressure despite a recent speculative rally. The company is in a precarious survival mode, having initiated a reverse stock split merely to maintain its Nasdaq listing, which often precedes further delisting risks or extreme volatility. Fundamentally, the business is deteriorating rapidly with negative earnings per share, negative free cash flow, and a return on equity of nearly -200%, indicating that capital is being destroyed rather than generated. There is no dividend to provide income, and the balance sheet shows significant debt relative to equity. While the price-to-book ratio appears artificially low due to the penny stock pricing, this is a value trap rather than a bargain, as the market correctly prices in the lack of sustainable operations and the high risk of total capital loss. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 26.807 |
| Beta | -0.88 |
| Website | https://www.cingulate.com |
| Attribute | Value |
|---|---|
| Address1 | 1,901 West 47th Place |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -0.884 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.689 |
| City | Kansas City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0087 |
| Current Ratio | 3.5 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0087 |
| Day Low | 0.0087 |
| Debt To Equity | 26.807 |
| Ebitda | -24,472,254 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -1.732 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0087 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0087 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0087 - 0.0087 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 14,203,583 |
| Free Cashflow | -12,838,706 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 14 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0087 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -8,521,635 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-12-08 |
| Language | en-US |
| Long Business Summary | Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas. |
| Long Name | Cingulate Inc. |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_1674914781 |
| Net Income To Common | -28,809,044 |
| Open | 0.0385 |
| Operating Cashflow | -20,654,108 |
| Operating Margins | 0.0 |
| Phone | 913 942 2300 |
| Previous Close | 0.0032 |
| Price Hint | 4 |
| Price To Book | 0.005150977 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.3 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0055 |
| Regular Market Change Percent | 171.875 |
| Regular Market Day High | 0.0087 |
| Regular Market Day Low | 0.0087 |
| Regular Market Day Range | 0.0087 - 0.0087 |
| Regular Market Open | 0.0385 |
| Regular Market Previous Close | 0.0032 |
| Regular Market Price | 0.0087 |
| Regular Market Time | 1,792,000,400 |
| Regular Market Volume | 25,000 |
| Return On Assets | -0.66940004 |
| Return On Equity | -1.9874 |
| Sand P52 Week Change | 0.16440773 |
| Sector | |
| Sector Key | |
| Short Name | Cingulate Inc. Warrants |
| Source Interval | 15 |
| State | KS |
| Symbol | CINGW |
| Total Cash | 28,402,820 |
| Total Cash Per Share | 1.953 |
| Total Debt | 6,290,880 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.732 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 25,000 |
| Website | https://www.cingulate.com |
| Zip | 66,205 |